Saturday, June 13, 2026

Patent directory Β· USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code β€” or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1079 of 1,261
  1. US 7255850

    Methods for measuring rates of reserve cholesterol transport in vivo, as an index of anti-atherogenesis

    The Regents of the University of California Β· Granted Aug 14, 2007 Β· Expires Aug 9, 2027

    granted
  2. US 7253171

    Urea derivatives as integrin Ξ±4 antagonists

    Laboratories Almirall, S.A. Β· Granted Aug 7, 2007 Β· Expires Aug 2, 2027

    granted
  3. US 7253275

    Porin B (PorB) as a therapeutic target for prevention and treatment of infection by Chlamydia

    The Regents of the University of California Β· Granted Aug 7, 2007 Β· Expires Aug 2, 2027

    granted
  4. US 7253273

    Treatment of neuropathic pain with zinc finger proteins

    Sangamo Biosciences, Inc. Β· Granted Aug 7, 2007 Β· Expires Aug 2, 2027

    granted
  5. US 7253185

    Amino ceramide-like compounds and therapeutic methods of use

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Aug 7, 2007 Β· Expires Aug 2, 2027

    granted
  6. US 7252817

    Viruses for the treatment of cellular proliferative disorders

    ONCOLYTICS BIOTECH INC. Β· Granted Aug 7, 2007 Β· Expires Aug 2, 2027

    granted
  7. US 7253187

    Heterocyclic inhibitors of ERK2 and uses thereof

    Vertex Pharmaceuticals Incorporated Β· Granted Aug 7, 2007 Β· Expires Aug 2, 2027

    granted
  8. US 7253341

    Denaturant stable and/or protease resistant, chaperone-like oligomeric proteins, polynucleotides encoding same, their uses and methods of increasing a specific activity thereof

    Fulcrum SP Ltd. Β· Granted Aug 7, 2007 Β· Expires Aug 2, 2027

    granted
  9. US 7252996

    Ancillary composition for the preparation of committed mature dentritic cells

    I.D.M. Immuno-Designed Molecules Β· Granted Aug 7, 2007 Β· Expires Aug 2, 2027

    granted
  10. US 7252929

    Methods for identifying alpha PDGFR agonists and antagonists

    United State of America, As Represented by the Secretary, Dept. of Health and Human Services Β· Granted Aug 7, 2007 Β· Expires Aug 2, 2027

    granted
  11. US 7253147

    Modified serum albumin with reduced affinity for nickel and copper

    New Century Pharmaceuticals, Inc. Β· Granted Aug 7, 2007 Β· Expires Aug 2, 2027

    granted
  12. US 7252989

    Adenovirus supervector system

    The Board of Regents of the University of Texas System Β· Granted Aug 7, 2007 Β· Expires Aug 2, 2027

    granted
  13. US 7252819

    Methods and compositions for correction of cardiac conduction disturbances

    The Regents of the University of California Β· Granted Aug 7, 2007 Β· Expires Aug 2, 2027

    granted
  14. US 7250171

    Construction and use of recombinant parainfluenza viruses expressing a chimeric glycoprotein

    The United States of America as represented by the Secretary of the Dept. of Health & Human Services Β· Granted Jul 31, 2007 Β· Expires Jul 26, 2027

    granted
  15. US 7250272

    G protein-coupled receptor protein and DNA thereof

    Takeda Pharmaceutical Company Limited Β· Granted Jul 31, 2007 Β· Expires Jul 26, 2027

    granted
  16. US 7250182

    Medicament containing Epimedium extract for treatment of prostatic hyperplasia and prostatitis

    Bright Future Pharmaceutical Laboratories Β· Granted Jul 31, 2007 Β· Expires Jul 26, 2027

    granted
  17. US 7250414

    Diphenylmethyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. Β· Granted Jul 31, 2007 Β· Expires Jul 26, 2027

    granted
  18. US 7250400

    Peptides and derivatives thereof showing cell attachment, spreading and detachment activity

    REGENBiotech, Inc. Β· Granted Jul 31, 2007 Β· Expires Jul 26, 2027

    granted
  19. US 7250520

    Processes for preparing pyrroles

    Vertex Pharmaceuticals Incorporated Β· Granted Jul 31, 2007 Β· Expires Jul 26, 2027

    granted
  20. US 7250169

    Anti-tumor activity of Ea-4-peptide of pro-IGF-1

    UNIVERSITY OF CONNECTICUT Β· Granted Jul 31, 2007 Β· Expires Jul 26, 2027

    granted
  21. US 7247615

    Peptide agonists of prostate-specific antigen and uses therefor

    THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services Β· Granted Jul 24, 2007 Β· Expires Jul 19, 2027

    granted
  22. US 7247653

    Pharmaceutical composition

    Takeda Pharmaceutical Company Limited Β· Granted Jul 24, 2007 Β· Expires Jul 19, 2027

    granted
  23. US 7247316

    Compositions and methods for treating lymphoma

    The Board of Regents of the University of Texas System Β· Granted Jul 24, 2007 Β· Expires Jul 19, 2027

    granted
  24. US 7247716

    Recombinant sequence, its preparation and use

    University College Cardiff Consultants Limited Β· Granted Jul 24, 2007 Β· Expires Jul 19, 2027

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search β€” best for looking up a specific filing or applicant portfolio slice.